Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 2/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PYCR1 | P32322 | 1/20 | 0.31 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20562595 | 0.86 | L3MBTL1 (0.37) | SLC6A4HTR2AKCNH2L3MBTL1MEN1 | |
| SCHEMBL30994653 | 0.83 | SLC6A4 (0.33) | SLC6A4HTR2AKCNH2L3MBTL1MEN1 | |
| SCHEMBL20564011 | 0.79 | PTGDR2 (0.41) | SLC6A4HTR2AKCNH2L3MBTL1MEN1 | |
| SCHEMBL21940078 | 0.79 | CCR5 (0.39) | SLC6A4HTR2AKCNH2L3MBTL1PYCR1 | |
| SCHEMBL20563120 | 0.75 | CSNK2A1 (0.42) | SLC6A4HTR2AKCNH2L3MBTL1PYCR1 | |
| SCHEMBL15111147 | 0.75 | L3MBTL1 (0.33) | SLC6A4HTR2AKCNH2L3MBTL1MEN1 | |
| SCHEMBL29737932 | 0.74 | PTGDR2 (0.41) | L3MBTL1MEN1MAPTKMT2APTGER1 | |
| SCHEMBL20562760 | 0.74 | PTGDR2 (0.41) | L3MBTL1MEN1MAPTKMT2APTGER1 | |
| SCHEMBL682486 | 0.74 | MAPK1 (0.43) | SLC6A4L3MBTL1MEN1MAPTKMT2A | |
| SCHEMBL28176696 | 0.73 | L3MBTL1 (0.32) | SLC6A4HTR2AKCNH2L3MBTL1PTGER1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025149498-A1 | BENZYLPIPERIDINE DERIVATIVES AS TRP4 ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES | ASTRAZENECA AB (SE) | 2025-07-17 | — | — | WO | disclosed |